SRAMF (Sisram Medical) Accumulated Depreciation: $-20.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SRAMF Sisram Medical Ltd SRAMF
89 GF Score
Price $0.44
GF Value $1.01
! 5 Warning Signs
View Full Analysis

What is Sisram Medical Accumulated Depreciation?

Sisram Medical SRAMF 89 Accumulated Depreciation is $-20.6 Mil as of Dec. 2025. GuruFocus rates SRAMF with a GF Score™ of 89/100 and a GF Value™ of $1.01. The stock has 5 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Sisram Medical's quarterly accumulated depreciation declined from Dec. 2024 ($-17.1 Mil) to Jun. 2025 ($0.0 Mil) but then increased from Jun. 2025 ($0.0 Mil) to Dec. 2025 ($-20.6 Mil).

Sisram Medical's annual accumulated depreciation increased from Dec. 2023 ($-13.6 Mil) to Dec. 2024 ($-17.1 Mil) and increased from Dec. 2024 ($-17.1 Mil) to Dec. 2025 ($-20.6 Mil).


Sisram Medical Accumulated Depreciation Related Terms


Sisram Medical Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Sisram Medical's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sisram Medical Accumulated Depreciation Chart

Sisram Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.35 -10.69 -13.64 -17.09 -20.64

Sisram Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -17.09 0.00 -20.64 0.00
SRAMF
89GF Score
Sisram Medical Ltd SRAMF
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sisram Medical Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-20.6 Mil mean?
Sisram Medical (SRAMF) has a Accumulated Depreciation of $-20.6 Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Sisram Medical and its competitors.
Is Sisram Medical's Accumulated Depreciation too high?
Sisram Medical's current Accumulated Depreciation is $-20.6 Mil. Overall, Sisram Medical has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's Accumulated Depreciation compare to ABT and SYK?
Sisram Medical's Accumulated Depreciation of $-20.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Sisram Medical and its competitors. Sisram Medical's current Accumulated Depreciation is $-20.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Sisram Medical (SRAMF) has a current Accumulated Depreciation of $-20.6 Mil. The stock's GF Value™ is $1.01, compared to a current price of $0.44 — trading 56.6% below its estimated fair value. The current Accumulated Depreciation is $-20.6 Mil. Sisram Medical's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current Accumulated Depreciation is $-20.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sisram Medical (SRAMF) Overvalued in 2026?

Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued. The current stock price of $0.44 is trading 56.6% below its estimated GF Value™ of $1.01.

Key valuation signals for SRAMF:

  • Accumulated Depreciation: $-20.6 Mil
  • GF Value™: $1.01 vs. price of $0.44 (56.6% below fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sisram Medical Business Description

Other Exchanges 01696:Hong Kong
Address HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
89GF Score

Get the complete analysis for SRAMF

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$1.01
GF Value